* required field
* required field
Angelika Talar-Śpionek Pharmacist, Editor
6 months ago
At the moment, there is no approval from the EMA (European Medicines Agency) for the marketing authorisation of the Israeli drug EXO-CD24. The drug has no registration and is not yet available for commercial use.